Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating perivascular progenitors: a target of PDGFR inhibition.
Mancuso P, Martin-Padura I, Calleri A, Marighetti P, Quarna J, Rabascio C, Braidotti P, Bertolini F. Mancuso P, et al. Among authors: quarna j. Int J Cancer. 2011 Sep 15;129(6):1344-50. doi: 10.1002/ijc.25816. Epub 2011 Apr 13. Int J Cancer. 2011. PMID: 21128230
Complementary populations of human adipose CD34+ progenitor cells promote growth, angiogenesis, and metastasis of breast cancer.
Orecchioni S, Gregato G, Martin-Padura I, Reggiani F, Braidotti P, Mancuso P, Calleri A, Quarna J, Marighetti P, Aldeni C, Pruneri G, Martella S, Manconi A, Petit JY, Rietjens M, Bertolini F. Orecchioni S, et al. Among authors: quarna j. Cancer Res. 2013 Oct 1;73(19):5880-91. doi: 10.1158/0008-5472.CAN-13-0821. Epub 2013 Aug 5. Cancer Res. 2013. PMID: 23918796
Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses.
Mancuso P, Antoniotti P, Quarna J, Calleri A, Rabascio C, Tacchetti C, Braidotti P, Wu HK, Zurita AJ, Saronni L, Cheng JB, Shalinsky DR, Heymach JV, Bertolini F. Mancuso P, et al. Among authors: quarna j. Clin Cancer Res. 2009 Jan 1;15(1):267-73. doi: 10.1158/1078-0432.CCR-08-0432. Clin Cancer Res. 2009. PMID: 19118054
Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab.
Calleri A, Bono A, Bagnardi V, Quarna J, Mancuso P, Rabascio C, Dellapasqua S, Campagnoli E, Shaked Y, Goldhirsch A, Colleoni M, Bertolini F. Calleri A, et al. Among authors: quarna j. Clin Cancer Res. 2009 Dec 15;15(24):7652-7657. doi: 10.1158/1078-0432.CCR-09-1493. Clin Cancer Res. 2009. PMID: 19996223
A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy.
Bassi S, Rabascio C, Nassi L, Steffanoni S, Babic A, Bertazzoni P, Gigli F, Antoniotti P, Orlando L, Sammassimo S, Quarna J, Negri M, Martinelli G. Bassi S, et al. Among authors: quarna j. Transfus Apher Sci. 2010 Dec;43(3):321-326. doi: 10.1016/j.transci.2010.10.001. Epub 2010 Oct 30. Transfus Apher Sci. 2010. PMID: 21036667 Clinical Trial.
Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine.
Fadini GP, de Kreutzenberg SV, Mariano V, Boscaro E, Bertolini F, Mancuso P, Quarna J, Marescotti M, Agostini C, Tiengo A, Avogaro A. Fadini GP, et al. Among authors: quarna j. Diabetes Obes Metab. 2011 Aug;13(8):718-25. doi: 10.1111/j.1463-1326.2011.01396.x. Diabetes Obes Metab. 2011. PMID: 21410861 Clinical Trial.
14 results